Form 4: MGRX CEO Jacob Cohen Awarded 200,000 Share Bonus

MANGOCEUTICALS, INC. CEO Jacob D. Cohen received a discretionary bonus of 200,000 common shares, aligning his interests with shareholders.

Summary

• Jacob D. Cohen, Chief Executive Officer, Director, and 10% owner of MANGOCEUTICALS, INC. (MGRX), acquired 200,000 shares of common stock.
• The shares were issued on April 10, 2025, as a discretionary bonus in consideration for services rendered as Chief Executive Officer.
• The issuance was made under the registrant's Second Amended and Restated 2022 Equity Incentive Plan and is exempt pursuant to Rule 16b-3.
• Following this transaction, Mr. Cohen directly owns 200,000 shares of MANGOCEUTICALS, INC. common stock.
• Additionally, The Tiger Cub Trust, for which Mr. Cohen serves as Trustee and is a beneficial owner, holds 605,000 shares of common stock. Mr. Cohen disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

Sentiment

Score: 7

Explanation: The grant of a significant equity bonus to the CEO is generally viewed positively as it aligns management's interests with those of shareholders, incentivizing long-term performance. It reflects compensation for services rendered.

Positives

• CEO Jacob D. Cohen received a significant equity bonus, which typically enhances alignment between management's interests and those of shareholders.
• The equity grant was made under an established and approved equity incentive plan (Second Amended and Restated 2022 Equity Incentive Plan), indicating structured compensation practices.

Future Outlook

NA

Management Comments

• The 200,000 shares were issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer, under the registrant's Second Amended and Restated 2022 Equity Incentive Plan, and are exempt pursuant to Rule 16b-3.
• Jacob D. Cohen disclaims beneficial ownership of the securities held by The Tiger Cub Trust except to the extent of his pecuniary interest therein.

Industry Context

NA

Related Party Transactions

• Jacob D. Cohen, Chief Executive Officer, Director, and 10% owner, received 200,000 shares of common stock as a discretionary bonus from MANGOCEUTICALS, INC. for services rendered.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of the CEO's interests with shareholder value creation through equity ownership.
• Employees: May signal a commitment to performance-based compensation, though this specific grant is for the CEO.

Key Dates

Keywords

MANGOCEUTICALS, MGRX, Jacob Cohen, CEO, Stock Grant, Equity Incentive Plan, Form 4, Insider Transaction, Beneficial Ownership